Literature DB >> 11389813

Retinoid mechanisms and cyclins.

J O Boyle1.   

Abstract

Retinoids have been investigated for their effects in the prevention and treatment of cancer. Scores of synthetic and natural ligands suppress growth and normalize differentiation of cells in vitro and in vivo. The molecular mechanisms of these activities are being elucidated with the goal of improving the therapeutic index. Here we summarize recent advances in the understanding of retinoid signaling via nuclear receptors, corepressors, and coactivators and review the effects of retinoid treatment on cell-cycle control elements and cyclin proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389813     DOI: 10.1007/s11912-001-0081-9

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  39 in total

Review 1.  Retinoid receptors in health and disease: co-regulators and the chromatin connection.

Authors:  S Minucci; P G Pelicci
Journal:  Semin Cell Dev Biol       Date:  1999-04       Impact factor: 7.727

Review 2.  Ligand-protein interactions in nuclear receptors of hormones.

Authors:  P F Egea; B P Klaholz; D Moras
Journal:  FEBS Lett       Date:  2000-06-30       Impact factor: 4.124

3.  Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism.

Authors:  J Langenfeld; H Kiyokawa; D Sekula; J Boyle; E Dmitrovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Authors:  W K Hong; S M Lippman; L M Itri; D D Karp; J S Lee; R M Byers; S P Schantz; A M Kramer; R Lotan; L J Peters
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

5.  pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.

Authors:  S Panigone; S Debernardi; Y Taya; E Fontanella; R Airoldi; D Delia
Journal:  Oncogene       Date:  2000-08-17       Impact factor: 9.867

6.  Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis.

Authors:  M Li; A K Indra; X Warot; J Brocard; N Messaddeq; S Kato; D Metzger; P Chambon
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

7.  Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells.

Authors:  R M Neve; H Sutterlüty; N Pullen; H A Lane; J M Daly; W Krek; N E Hynes
Journal:  Oncogene       Date:  2000-03-23       Impact factor: 9.867

8.  Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286.

Authors:  D Germain; A Russell; A Thompson; J Hendley
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

9.  Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

Authors:  R Lotan; X C Xu; S M Lippman; J Y Ro; J S Lee; J J Lee; W K Hong
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

10.  Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines.

Authors:  K Hayashi; H Yokozaki; K Naka; W Yasui; R Lotan; E Tahara
Journal:  Jpn J Cancer Res       Date:  2001-01
View more
  6 in total

Review 1.  Role of retinoid signaling in the regulation of spermatogenesis.

Authors:  S S W Chung; D J Wolgemuth
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

2.  Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N-methyl-N-nitrosourea-induced rat mammary carcinoma model and its effects on the uterus.

Authors:  Paul E Goss; Shangle Qi; Haiqing Hu; Lalji K Gediya; Puranik Purushottamachar; Abhijit M Godbole; Vincent C O Njar
Journal:  Breast Cancer Res Treat       Date:  2011-08-14       Impact factor: 4.872

3.  Retinoic acid promotes primary fetal alveolar epithelial type II cell proliferation and differentiation to alveolar epithelial type I cells.

Authors:  Rui-wei Gao; Xiang-yong Kong; Xiao-xi Zhu; Guo-qing Zhu; Jin-shuai Ma; Xiu-xiang Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-17       Impact factor: 2.416

4.  Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis.

Authors:  Yuan-Han Qin; Feng-Ying Lei; Peng Hu; Juan Pei; Zhen-Bo Feng; Yu-Sheng Pang
Journal:  Pediatr Nephrol       Date:  2009-04-09       Impact factor: 3.714

5.  Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.

Authors:  Thehang Luu; Paul Frankel; Jan H Beumer; Dean Lim; Mihaela Cristea; Leonard J Appleman; Heinz J Lenz; David R Gandara; Brian F Kiesel; Richard L Piekarz; Edward M Newman
Journal:  Cancer Chemother Pharmacol       Date:  2019-09-14       Impact factor: 3.333

6.  Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.

Authors:  J B Patel; J Mehta; A Belosay; G Sabnis; A Khandelwal; A M H Brodie; D R Soprano; V C O Njar
Journal:  Br J Cancer       Date:  2007-03-27       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.